VWM
BIIB icon

Vermillion Wealth Management’s Biogen BIIB Stock Holding History

Vermillion Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-310
Closed -$56.8K – 1641
2026
Q1 		$56.8K Buy
310
+10
+3% +$1.84K 0.02% 190
2025
Q4 		$52.8K Buy
+300
New +$49K 0.02% 193
2025
Q2 		– Sell
-300
Closed -$41.1K – 540
2025
Q1 		$41.1K Hold
300
– – 0.01% 557
2024
Q4 		$45.9K Buy
+300
New +$50.6K 0.02% 185

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vermillion Wealth Management's BIIB Position: Q2 2026 in Review

Vermillion Wealth Management sold out of Biogen (BIIB) in Q2 2026, closing a stake of 310 shares — an estimated $56.8K sold.

Vermillion Wealth Management first reported a position in BIIB in Q4 2024 and held it in 4 quarters. The position peaked at $56.8K in Q1 2026. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Vermillion Wealth Management reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
  • Vermillion Wealth Management sold 310 Biogen shares in Q2 2026, an estimated $56.8K.
  • Vermillion Wealth Management first reported a position in Biogen in Q4 2024 and held it in 4 quarters.
  • Vermillion Wealth Management's Biogen position peaked at $56.8K in Q1 2026.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.